HCP5 genetic variant (RS3099844) contributes to Nevirapine-induced Stevens Johnsons Syndrome/Toxic Epidermal Necrolysis susceptibility in a population from Mozambique

Association of Human Leukocyte Antigen Alleles and Nevirapine Hypersensitivity in a Malawian HIV-Infected Population

(2013) Daniel F. Carr et al.   CLINICAL INFECTIOUS DISEASES

Association between CYP2B6 polymorphisms and Nevirapine-induced SJS/TEN: a pharmacogenetics study

(2013) Cinzia Ciccacci et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

HLA Genotype and Carbamazepine-Induced Cutaneous Adverse Drug Reactions: A Systematic Review

(2012) V L Yip et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Incidence of Toxic Epidermal Necrolysis and Stevens-Johnson Syndrome in an HIV Cohort

(2011) Nicole Mittmann et al.   AMERICAN JOURNAL OF CLINICAL DERMATOLOGY

Association of HLA-B*5801 allele and allopurinol-induced stevens johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis

(2011) Ratchadaporn Somkrua et al.   BMC Medical Genetics

Genome-wide association study of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Europe

(2011) Emmanuelle Génin et al.   Orphanet Journal of Rare Diseases

A whole-genome association study of major determinants for allopurinol-related Stevens–Johnson syndrome and toxic epidermal necrolysis in Japanese patients

(2011) M Tohkin et al.   PHARMACOGENOMICS JOURNAL

Arlequin suite ver 3.5: a new series of programs to perform population genetics analyses under Linux and Windows

(2010) LAURENT EXCOFFIER et al.   Molecular Ecology Resources